Literature DB >> 22451332

Macrophage migration inhibitory factor gene polymorphisms and plasma levels in children with obstructive sleep apnea.

Abdelnaby Khalyfa1, Leila Kheirandish-Gozal, Oscar Sans Capdevila, Rakesh Bhattacharjee, David Gozal.   

Abstract

INTRODUCTION: Obstructive sleep apnea (OSA) is associated with increased risk for cardiovascular and metabolic dysfunction in both adults and children. In adults with OSA, serum levels of macrophage migration inhibitory factor (MIF) are elevated. Therefore, we assessed plasma MIF levels and MIF allelic variant frequencies in children with and without OSA (NOSA).
METHODS: A total of 614 consecutive children ages 5-8 years were recruited. Children were divided into those with OSA and NOSA based on the apnea-hypopnea index (AHI). In addition to lipid profile, hsCRP, and fasting insulin and glucose levels, plasma MIF levels were assayed using ELISA, and 28 single nucleotide polymorphisms (SNPs) covering the region were genotyped. Linkage disequilibrium and haplotype blocks were analyzed using Haploview version 4.2 software.
RESULTS: Morning plasma MIF levels were increased in children with OSA. Of the 28 SNPs tested, the frequency of rs10433310 minor allele was significantly decreased in OSA. This SNP was also associated with reduced fasting insulin and hsCRP levels in OSA. The minor allele frequency of all other 27 SNPs was similar in OSA and NOSA groups.
CONCLUSIONS: Childhood OSA is associated with higher plasma MIF, hsCRP, and fasting insulin levels that promote cardiometabolic risk, and the MIF gene SNP rs10433310 may account for some of the variance in such risk.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22451332      PMCID: PMC3405200          DOI: 10.1002/ppul.22560

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  67 in total

1.  Genetic variation in macrophage migration inhibitory factor associated with gestational diabetes mellitus and metabolic syndrome.

Authors:  S Aslani; A Hossein-nezhad; Z Maghbooli; K Mirzaei; F Karimi
Journal:  Horm Metab Res       Date:  2011-04-21       Impact factor: 2.936

2.  Functional promoter polymorphisms of macrophage migration inhibitory factor in peptic ulcer diseases.

Authors:  Hisakazu Shiroeda; Tomomitsu Tahara; Tomoyuki Shibata; Masakatsu Nakamura; Hideto Yamada; Tomoe Nomura; Ranji Hayashi; Takashi Saito; Tomoki Fukuyama; Toshimi Otsuka; Hirokazu Yano; Kazuaki Ozaki; Mutsumi Tsuchishima; Mikihiro Tsutsumi; Tomiyasu Arisawa
Journal:  Int J Mol Med       Date:  2010-11       Impact factor: 4.101

Review 3.  Autoimmune diseases: MIF as a therapeutic target.

Authors:  Dorothee Greven; Lin Leng; Richard Bucala
Journal:  Expert Opin Ther Targets       Date:  2010-03       Impact factor: 6.902

4.  Polymorphisms of the macrophage migration inhibitory factor gene in a UK population with Type 1 diabetes mellitus.

Authors:  R J L Martin; D A Savage; D J Carson; A J McKnight; A P Maxwell; C C Patterson
Journal:  Diabet Med       Date:  2010-02       Impact factor: 4.359

5.  De novo expression of macrophage migration inhibitory factor in atherogenesis in rabbits.

Authors:  S G Lin; X Y Yu; Y X Chen; X R Huang; C Metz; R Bucala; C P Lau; H Y Lan
Journal:  Circ Res       Date:  2000-12-08       Impact factor: 17.367

6.  Expression of macrophage migration inhibitory factor in different stages of human atherosclerosis.

Authors:  Anke Burger-Kentischer; Heike Goebel; Rüdiger Seiler; Gustav Fraedrich; Hans E Schaefer; Stefanie Dimmeler; Robert Kleemann; Jürgen Bernhagen; Christian Ihling
Journal:  Circulation       Date:  2002-04-02       Impact factor: 29.690

7.  Serum adipocyte-fatty acid binding protein level is elevated in severe OSA and correlates with insulin resistance.

Authors:  D C-L Lam; A Xu; K S-L Lam; B Lam; J C-M Lam; M M-S Lui; M S-M Ip
Journal:  Eur Respir J       Date:  2009-02       Impact factor: 16.671

8.  Childhood Obstructive Sleep Apnea: One or Two Distinct Disease Entities?

Authors:  Ehab Dayyat; Leila Kheirandish-Gozal; David Gozal
Journal:  Sleep Med Clin       Date:  2007-09

9.  Proinflammatory genetic profiles in subjects with history of ischemic stroke.

Authors:  Andrea Flex; Eleonora Gaetani; Pierangelo Papaleo; Giuseppe Straface; Anna S Proia; Giovanni Pecorini; Paolo Tondi; Paolo Pola; Roberto Pola
Journal:  Stroke       Date:  2004-08-12       Impact factor: 7.914

10.  Prevalence of epileptiform activity in healthy children during sleep.

Authors:  Oscar Sans Capdevila; Ehab Dayyat; Leila Kheirandish-Gozal; David Gozal
Journal:  Sleep Med       Date:  2007-07-16       Impact factor: 3.492

View more
  8 in total

Review 1.  Biomarkers associated with obstructive sleep apnea: A scoping review.

Authors:  Graziela De Luca Canto; Camila Pachêco-Pereira; Secil Aydinoz; Paul W Major; Carlos Flores-Mir; David Gozal
Journal:  Sleep Med Rev       Date:  2014-11-28       Impact factor: 11.609

2.  That's not it, either-neither polymorphisms in PHOX2B nor in MIF are involved in sudden infant death syndrome (SIDS).

Authors:  Micaela Poetsch; Rebecca Todt; Mechtild Vennemann; Thomas Bajanowski
Journal:  Int J Legal Med       Date:  2015-06-24       Impact factor: 2.686

Review 3.  Diagnostic capability of biological markers in assessment of obstructive sleep apnea: a systematic review and meta-analysis.

Authors:  Graziela De Luca Canto; Camila Pachêco-Pereira; Secil Aydinoz; Paul W Major; Carlos Flores-Mir; David Gozal
Journal:  J Clin Sleep Med       Date:  2015-01-15       Impact factor: 4.062

Review 4.  Genotype-phenotype interactions in pediatric obstructive sleep apnea.

Authors:  Leila Kheirandish-Gozal; David Gozal
Journal:  Respir Physiol Neurobiol       Date:  2013-04-03       Impact factor: 1.931

Review 5.  The Mystery of Red Blood Cells Extracellular Vesicles in Sleep Apnea with Metabolic Dysfunction.

Authors:  Abdelnaby Khalyfa; David Sanz-Rubio
Journal:  Int J Mol Sci       Date:  2021-04-21       Impact factor: 5.923

6.  Polymorphisms in nitric oxide synthase and endothelin genes among children with obstructive sleep apnea.

Authors:  Siriporn Chatsuriyawong; David Gozal; Leila Kheirandish-Gozal; Rakesh Bhattacharjee; Ahamed A Khalyfa; Yang Wang; Wasana Sukhumsirichart; Abdelnaby Khalyfa
Journal:  BMC Med Genomics       Date:  2013-09-06       Impact factor: 3.063

Review 7.  Evaluation of Blood Levels of C-Reactive Protein Marker in Obstructive Sleep Apnea: A Systematic Review, Meta-Analysis and Meta-Regression.

Authors:  Mohammad Moslem Imani; Masoud Sadeghi; Farid Farokhzadeh; Habibolah Khazaie; Serge Brand; Kenneth M Dürsteler; Annette Brühl; Dena Sadeghi-Bahmani
Journal:  Life (Basel)       Date:  2021-04-19

8.  Endothelial Dysfunction in Children With Obstructive Sleep Apnea Is Associated With Elevated Lipoprotein-Associated Phospholipase A2 Plasma Activity Levels.

Authors:  Leila Kheirandish-Gozal; Mona F Philby; Zhuanghong Qiao; Abdelnaby Khalyfa; David Gozal
Journal:  J Am Heart Assoc       Date:  2017-02-09       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.